ITP Conference 2007

Professional Program

“Immune-Mediated Thrombocytopenia: ITP and Beyond”

A Continuing Medical Education Seminar jointly sponsored by Weill Medical College of Cornell University and the Platelet Disorder Support Association

Friday, June 15

6:30 PM - 9:00 PM

Panel discussion followed by a question and answer session
“How are platelets made and what happens in ITP” – Amy Geddis, MD
“How are platelets destroyed and how do we interrupt it: mechanisms of effects of IVIg's” - AlanLazarus, PhD “Secondary ITP: what are some of the causes of ITP” - Howard Liebman, MD

Saturday, June 16

9:00 AM - 11:30 AM

Panel discussion followed by a question and answer session
“UK treatment guidelines” – Nichola Cooper, MD
“US treatment guidelines” - Jeffrey Wasser, MD
“Guidelines in children with ITP” - Mike Tarantino, MD

12:00 PM - 2:00 PM

Concurrent sessions
Moderated question and answer sessions
Medical professionals and patients exchange views

2:15 PM - 4:45 PM

Panel discussion followed by a question and answer session
“ASH highlights” - John Semple, PhD
“ Novel treatment approaches” – James Bussel, MD
“ Thrombopoietic agents” - Terry Gernsheimer, MD

4:45 PM – 5:00 PM

CME evaluations and conference wrap-up

This course is designed for hematologists and hematologist/ oncologists who are treating patients diagnosed with ITP and/or related disorders. Other allied health professionals and some patients may also find this information useful and may attend. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Weill Medical College of Cornell University and the Platelet Disorder Support Association. The Weill Medical College of Cornell University is accredited by the ACCME to provide continuing medical education for physicians.

Weill Medical College of Cornell University designates this educational activity for a maximum of 8.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.